Item 7.01. Regulation FD Disclosure
On June 10, 2010, beginning at 9:00 a.m., Eastern Standard Time, the 2010 Annual Meeting of Stockholders of NovaDel Pharma Inc., a Delaware corporation (the “Company”), will be held at the offices of Morgan, Lewis & Bockius LLP, located at 502 Carnegie Center, Princeton, New Jersey 08540. In connection with this meeting, the Company has made available for review on its website an updated copy of its Corporate Presentation at www.novadel.com. A copy of the Corporate Presentation is attached hereto as Exhibit 99.1.
The information furnished pursuant to this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
99.1
|
|
NovaDel Pharma Inc. Corporate Presentation dated June 9, 2010.
|
| |
|
|
F 888.329.6696